Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D
Your doctor will convert your current dose to an equivalent compounded dose with no titration restart required
Heres what responsible prescribing looks like Shopping for GLP-1 prescriptions for weight loss
Most people experience fatigue during the initial weeks of GLP-1 treatment, particularly during dose titration, with improvement occurring over several weeks to months as the body adapts
Tesamorelin is primarily prescribed for HIV-related lipodystrophy and has a more targeted effect on reducing visceral fat
US$ 28.28
US$ 27.71
US$ 25.88
